Article

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

2022-03-12

Abstract excerpt

<h4>Background</h4> Therapies targeting the androgen receptor (AR) have improved the outcome for patients with castration-sensitive prostate cancer (CSPC). Expression of the constitutively active AR splice variant-7 (AR-V7) has shown clinical utility as a predictive biomarker of AR-targeted therapy resistance in castration-resistant prostate cancer (CRPC), but its importance as predictive biomarker in CSPC remains...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b11c846c-5682-5faf-a3f8-bcee3b9834f1
DOI: 10.1101/2022.03.10.22271799

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancerDOI 10.1101/2022.03.10.22271799Read

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancerSemantic proximity Read

Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers.Semantic proximity Read

The Clinicopathological Characteristics of Androgen Receptor Splicing Variant 7 (AR-V7) Expression in Patients with Castration Resistance Prostate Cancer: A Systematic Review and Meta‐AnalysisSemantic proximity Read

<scp>Androgen receptor</scp> splice variant 7 in castration‐resistant prostate cancer: Clinical considerationsSemantic proximity Read

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.Semantic proximity Read

CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.Semantic proximity Read

Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.Semantic proximity Read

AR Splicing Variants and Resistance to AR Targeting AgentsSemantic proximity Read

Decoding the androgen receptor splice variants.Semantic proximity Read

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.Semantic proximity Read

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancerSemantic proximity Read

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate CancerSemantic proximity Read